Sector Alpha

Track where the smart money flows in Indian equities

DashboardWeekly UpdateSector Deep DivesUploadPipelinePE CyclesBrainAboutHow We Research

Data updated weekly. Not financial advice.

Sector Alpha
  1. Home
  2. /Momentum
  3. /Pharmaceuticals Bulk Drugs & Formulation
  4. /Amanta Healthcare Ltd
MomentumDeep Value

Amanta Healthcare Ltd: Why Is It Outperforming Nifty 500?

Active
RS +55.2%Weak4w StreakRe-Entry

In Week of Jul 10, 2026, Amanta Healthcare Ltd (Pharmaceuticals Bulk Drugs & Formulation) is outperforming Nifty 500 with +55.2% relative strength. Fundamentals: Weak. On a 4-week streak.

Amanta Healthcare Ltd Key Facts

PE Ratio
42.3x
Market Cap
₹696 Cr
PAT Growth YoY
-7%
Revenue Growth YoY
+7%
OPM
19.4%
RS vs Nifty 500
+55.2%
Emerging Opportunity

What's Happening

⏳Steady earner with flat PE — waiting for re-rate catalyst
💪Debt reduced 24% YoY — balance sheet strengthening
🏛️DII reducing — stake down 1.5%

Key Numbers

PAT Growth YoY
-7%
Inflection Down
Revenue YoY
+7%
Inflection Up
Operating Margin
19.4%
-688 bps YoY
PE Ratio
42.3
Current Price
₹179
Fundamental Score
32/100
Weak
3Y PAT CAGR
+80%
Market Cap
696 Cr
Valuation
Fairly Valued

12-Week Performance

Weekly presence in the outperformers list. Green = beating Nifty 500 by 10%+ that week.

12 weeks agoThis week

How Fast Is Amanta Healthcare Ltd Growing?

Revenue, profit and margin growth rates

MetricYoY3Y CAGRTrend
Revenue+7%+4%Inflection Up
PAT (Net Profit)-7%+80%Inflection Down
OPM19.4%-688 bpsVolatile

Other Top Pharmaceuticals Bulk Drugs & Formulation Stocks Beating Nifty 500

Alivus Life Sciences Ltd
Average
+6.4%
Sudeep Pharma Ltd
Average • 5w streak
+30.8%
← Back to Pharmaceuticals Bulk Drugs & FormulationDashboard

Frequently Asked Questions: Amanta Healthcare Ltd

Based on publicly available financial data. This is educational research, not investment advice.

What were Amanta Healthcare Ltd's latest quarterly results?

Amanta Healthcare Ltd's latest quarterly results (Mar 2026) show

  • PAT Growth YoY: -7.2% (inflecting downward)
  • Revenue Growth YoY: +6.8%
  • Operating Margin: 19.4% (volatile)

Is Amanta Healthcare Ltd's profit growing or declining?

Amanta Healthcare Ltd's profit is declining with an inflecting downward trend.

  • PAT Growth YoY: -7.2% (latest quarter)
  • PAT Growth QoQ: +19.4% (sequential)
  • 3-Year PAT CAGR: +80.0%
  • Trend: Inflecting downward — consistent growth pattern

What is Amanta Healthcare Ltd's revenue growth trend?

Amanta Healthcare Ltd's revenue growth trend is turning around (inflection up).

  • Revenue Growth YoY: +6.8%
  • Revenue Growth QoQ: +3.4% (sequential)
  • 3-Year Revenue CAGR: +3.6%

How is Amanta Healthcare Ltd's operating margin trending?

Amanta Healthcare Ltd's operating margin is volatile.

  • Current OPM: 19.4%
  • OPM Change YoY: -6.9% basis points
  • OPM Change QoQ: -1.2% basis points

What is Amanta Healthcare Ltd's 3-year profit and revenue CAGR?

Amanta Healthcare Ltd's long-term compounding rates

  • 3-Year Profit CAGR: +80.0%
  • 3-Year Revenue CAGR: +3.6%

Is Amanta Healthcare Ltd's growth accelerating or decelerating?

Amanta Healthcare Ltd's earnings growth is inflecting downward with mixed signals on a sequential basis.

  • YoY Acceleration: -15.4% bps
  • Sequential Acceleration: -30.6% bps
  • Margin Warning: Operating margins are under pressure

What is Amanta Healthcare Ltd's trailing twelve month (TTM) performance?

Amanta Healthcare Ltd's trailing twelve month (TTM) performance

  • TTM PAT: ₹15 Cr
  • TTM PAT Growth: +22.6% YoY
  • TTM Revenue: ₹288 Cr
  • TTM Revenue Growth: +4.7% YoY
  • TTM Operating Margin: 20.8%

Is Amanta Healthcare Ltd overvalued or undervalued?

Amanta Healthcare Ltd appears fairly valued based on our fair value analysis.

  • Valuation Signal: Fairly Valued
  • Current PE: 42.3x
  • Price-to-Book: 3.2x

What is Amanta Healthcare Ltd's current PE ratio?

Amanta Healthcare Ltd's current PE ratio is 42.3x.

  • Current PE: 42.3x
  • Market Cap: 696 Cr

How does Amanta Healthcare Ltd's valuation compare to its history?

Amanta Healthcare Ltd's current PE is 42.3x.

  • Current PE: 42.3x
  • Valuation Assessment: Fairly Valued

What is Amanta Healthcare Ltd's price-to-book ratio?

Amanta Healthcare Ltd's price-to-book ratio is 3.2x.

  • Price-to-Book (P/B): 3.2x
  • Book Value per Share: ₹57
  • Current Price: ₹179

Is Amanta Healthcare Ltd a fundamentally strong company?

Amanta Healthcare Ltd is rated Weak with a fundamental score of 32.15/100. This score is calculated from objective financial metrics

  • Revenue Growth YoY: +6.8% (10% weight)
  • PAT Growth YoY: -7.2% (10% weight)
  • PAT Growth QoQ: +19.4% (10% weight)
  • Margins stable (10% weight)

Is Amanta Healthcare Ltd debt free?

Amanta Healthcare Ltd's debt position

  • Total Debt: ₹244 Cr

What is Amanta Healthcare Ltd's return on equity (ROE) and ROCE?

Amanta Healthcare Ltd's return ratios over recent years

  • FY2024: ROCE 14.0%
  • FY2025: ROCE 15.0%
  • FY2026: ROCE 12.0%

Is Amanta Healthcare Ltd's cash flow positive?

Amanta Healthcare Ltd's operating cash flow is positive (FY2026).

  • Cash from Operations (CFO): ₹48 Cr
  • Free Cash Flow (FCF): ₹-46 Cr
  • CFO/PAT Ratio: 320% (strong cash conversion)

What is Amanta Healthcare Ltd's dividend yield?

Amanta Healthcare Ltd currently does not pay a significant dividend (yield 0.00%).

  • Dividend Yield: 0.00%
  • Current Price: ₹179

Who holds Amanta Healthcare Ltd shares — promoters, FII, DII?

Amanta Healthcare Ltd's shareholding pattern (Mar 2026)

  • Promoters: 63.7%
  • FII (Foreign): 0.8%
  • DII (Domestic): 12.9%
  • Public: 22.6%

Is promoter holding increasing or decreasing in Amanta Healthcare Ltd?

Amanta Healthcare Ltd's promoter holding has increased recently.

  • Current Promoter Holding: 63.7% (Mar 2026)
  • Previous Quarter: 63.6% (Dec 2025)
  • Change: +0.16% (increasing — positive signal)

How long has Amanta Healthcare Ltd been outperforming Nifty 500?

Amanta Healthcare Ltd has been outperforming Nifty 500 for 4 consecutive weeks, indicating building momentum.

Is Amanta Healthcare Ltd a new momentum entry or an established outperformer?

Amanta Healthcare Ltd is a re-entry — it briefly dropped off the outperformance list but has now returned. Re-entries can signal renewed strength.

Is Amanta Healthcare Ltd worth studying for long term investment?

Based on quantitative research signals, here is why Amanta Healthcare Ltd may be worth studying

  • Cash flow is positive — CFO ₹48 Cr

What is the investment thesis for Amanta Healthcare Ltd?

Amanta Healthcare Ltd investment thesis summary:

Risk Factors (Bear Case)

  • Margins under pressure

What is the future outlook for Amanta Healthcare Ltd?

Amanta Healthcare Ltd's forward outlook based on current data signals

  • Earnings Trend: inflecting downward
  • Revenue Trend: turning around (inflection up)
  • Margin Trend: volatile
  • Valuation: Fairly Valued

The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.